Innovation

Multiplex Real-Time PCR for PCV2a and PCV2b Identification

Kansas State University
posted on 03/08/2011

Research at Kansas State University has produced a new multiplex real-time PCR method for differentiating between major strains PCV2a and PCV2b. However, in recent years a new variant strain of PCV2b has developed and become fairly prevalent in Asia and Europe. As a result, research has been conducted and a new real-time PCR detection method to differentiate between the two major strains, PCV2a and PCV2b, as well as the new PCV2b variant has been created at K-State. Compared to the previous real-time PCR identification method, which only had 60% maximum detection for PCV2a/b with the inclusion of the new variant, the new method detects between 94 and 97% of all known, major variant strains tested. Circovirus associated diseases in swine are of increasing concern to producers around the world. Much remains unknown concerning the transmission, pathogenesis, epidemiology, and control of risk factors involved in the expression of circovirus associated diseases such as postweaning multisystemic wasting syndrome (PMWS), porcine dermatitis and nephropathy syndrome (PDNS), porcine respiratory disease complex (PRDC), and sporadic cases of PCV2-associated reproductive failure. In recent years, two major strains (PCV2 a and b) and various minor strains have developed. The complex nature of the virus and its’ strains have made both detection and treatment difficult to date.

Suggested Uses

Successful detection of PCV2 strains is essential for proper treatment, vaccination and ultimately, a cure. As a result, this technology would be potentially useful to:
  • Commercial diagnostic companies
  • Companies researching new vaccines
  • Academic researchers

Advantages

There are few successful detection methods for PCV2. The dynamic nature of the virus only adds to the difficulty. Therefore, this new real-time PCR method with up to 97% accurate detection for all major strains could be the most effective technology to date.

Innovation Details
 

File Number: 10-16 

Other Information: Provisional patent application filed in August 2010.

Interested parties should contact: National Institute for Strategic Technology Acquisition and Commercialization (NISTAC) 2005 Research Park Circle Manhattan, KS 66502

Tel: 785-532-3900 Fax: 785-532-3909 E-Mail: nistac@ksu.edu


IP Protection


License Online

This innovation currently is not available for online licensing. Please contact National Institute for Strategic Technology Acquisition & Commercialization at Kansas State University for more information.

Request more info via email request more info
People

Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

8,793 members 16,677 innovations 159 organizations

Browse

Dr. Jörg Knäblein – Technology Scouting, Bayer Schering Pharma AG

"Through the iBridge Network, I was able to find a mouse model I was looking for. The collaboration available through the iBridge Network is crucial in driving innovation and I'll continue using it as a valued resource."  read more...